HRES 685
Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 12:16 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This resolution urges support for routinely testing pregnant women for antiphospholipid syndrome (APS) as part of prenatal screening. APS is a condition where the body’s immune system mistakenly attacks blood vessels, increasing the risk of pregnancy complications like miscarriage. Currently, testing is only recommended in cases of unexplained fetal loss, but this bill aims to make APS screening a standard practice to potentially save babies and reduce family hardship. It also calls on medical organizations to revise their guidelines to reflect this recommendation.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.